regenerative medicine Archives

Business

Tech Giants and Agencies Brace for AI‑Powered Cyber Threats Amid Major Legal Settlements

By Norman Pearlstine

OpenAI, Anthropic and over 100 firms warn of imminent AI‑enabled cyberattacks while Meta settles a $16.7 billion child‑safety lawsuit and ICE budgets over $1 million for robot dogs.

Comments closed

FDA approves oral pancreatic cancer drug Rasonque with $477,000 annual list price

By Mitchell Landsberg

Revolution Medicines' oral tablet Rasonque received FDA clearance, showing a 60% mortality reduction but carrying a list price of roughly $477,000 per year.

Comments closed

Meta agrees $17 billion settlement, pledges new teen safety rules

By Helene Elliott

Meta will pay up to $17.1 billion and adopt limits on Instagram and Facebook use for minors, a move welcomed by child‑health experts but whose impact remains to be seen.

Comments closed

Five Business Lessons From the OpenAI‑Hugging Face Security Breach

By Norman Pearlstine

The July hack of Hugging Face by OpenAI highlights critical security gaps, from inadequate sandboxing to cultural oversights, offering five concrete lessons for businesses.

Comments closed

Bloom Energy Stock Down 38% From High, Analysts See Modest Upside

By Mitchell Landsberg

Bloom Energy shares have risen 149% in 2026 but remain 38% below their 52‑week peak, with analysts forecasting a modest rise to a median $295 target by August 2027.

Comments closed

Science

Tech Giants and Agencies Brace for AI‑Powered Cyber Threats Amid Major Legal Settlements

By Norman Pearlstine

OpenAI, Anthropic and over 100 firms warn of imminent AI‑enabled cyberattacks while Meta settles a $16.7 billion child‑safety lawsuit and ICE budgets over $1 million for robot dogs.

Comments closed

FDA approves oral pancreatic cancer drug Rasonque with $477,000 annual list price

By Mitchell Landsberg

Revolution Medicines' oral tablet Rasonque received FDA clearance, showing a 60% mortality reduction but carrying a list price of roughly $477,000 per year.

Comments closed

Meta agrees $17 billion settlement, pledges new teen safety rules

By Helene Elliott

Meta will pay up to $17.1 billion and adopt limits on Instagram and Facebook use for minors, a move welcomed by child‑health experts but whose impact remains to be seen.

Comments closed

Five Business Lessons From the OpenAI‑Hugging Face Security Breach

By Norman Pearlstine

The July hack of Hugging Face by OpenAI highlights critical security gaps, from inadequate sandboxing to cultural oversights, offering five concrete lessons for businesses.

Comments closed

Bloom Energy Stock Down 38% From High, Analysts See Modest Upside

By Mitchell Landsberg

Bloom Energy shares have risen 149% in 2026 but remain 38% below their 52‑week peak, with analysts forecasting a modest rise to a median $295 target by August 2027.

Comments closed

A groundbreaking therapy aimed at reversing cellular aging has been administered to the first human participant in a world-first clinical trial, marking a significant milestone in longevity research.

Posts tagged as “regenerative medicine”

Breakthrough In Joint Regrowth

First Human Trial of Cellular Rejuvenation Therapy Begins